Effects of Resistance Training in Multiple Sclerosis: a Randomized Trial. ACTIVE (Physical Activity and Its Impact on Patients With Multiple Sclerosis.)

Status unknownNot a drug-phase studyMS (type not specified)NCT06478784

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Resistance training

Compared with

  • Low aerobic training

What it measured

Main measures

  • Comparison of plasma light chain neurofilaments (Nfl) level

    10 Weeks

    Blood or spinal fluid markersPhysical function

Other measures (1)

  • Comparison of plasma Glial fibrillary acidic protein (GFAP) level

    10 weeks

    Blood or spinal fluid markersPhysical function

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

1. - Diagnosis of multiple sclerosis according to the 2017 Mc Donald criteria (Thompson A et al). 2. - Age > 18 years - up to no age limit 3. - Disability assessed by the EDSS (Expanded disability status scale) with a score less than or equal to 4. 4. - Clinical stability. Not having had an outbreak of the disease in the last 6 months. 5. - No changes in the disease-modifying treatment in the last 6 months or no treatment. 6. - Radiological stability. Patients with last MRI (magnetic resonance imaging) performed without inflammatory activity (absence of new lesions on T2 sequences or lesions that enhance with gadolinium). 7. - They must sign the informed consent

Exclusion criteria

1. - Patients with a high level of physical activity according to the International Physical Activity Questionnaire(IPAQ) or latest WHO (World Health Organization) recommendations on physical activity 2. - Pregnant or breastfeeding patients. 3. - Concomitant pathologies that limit the performance of physical exercise

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This is a longitudinal study to examine the effects of a short-term training program on neurofilamet and GFAP plasma levels. Participants will be divided in two groups: control group (moderate aerobic training) and active group (resistance training). The change in biomarkers will be analyzed pre and post intervention in both groups. Differences between groups will be also evaluated by investigators.

Papers

Loading reviews and guidelines…

History

    1. Started

      Jan 2024

    2. Main results due

      Dec 2024

    3. Finished

      Jan 2025

    Assembled by software from public sources.